Improved Aequorin for Ca Assay in Functioning Cells
改进的水母发光蛋白用于功能细胞中 Ca 的测定
基本信息
- 批准号:9101712
- 负责人:
- 金额:$ 28.94万
- 依托单位:
- 依托单位国家:美国
- 项目类别:Continuing Grant
- 财政年份:1991
- 资助国家:美国
- 起止时间:1991-08-01 至 1995-01-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
The photoprotein aequorin, first isolated by the P.I. in 1962, has been widely used as a calcium indicator in living cells. The preparations of aequorin used in the past were undefined mixtures of many isoaequorins. Recently, three categories of improved forms of aequorin were prepared in this laboratory: 1) homogeneous isoaequorins isolated from heterogeneous aequorin, 2) recombinant aequorin prepared by molecular cloning, and 3) semi-synthetic aequorins obtained by replacing the functional group of various aequorins with various synthetic analogs. Semi-synthetic aequorins have highly advantageous properties in measuring intracellular calcium but are not yet fully utilized. The main objective of this project is to improve the usability of the new types of aequorin. Studies planned include: 1) detailed investigation concerning the calcium triggered luminescence of semi-synthetic aequorins, to improve the effective utilization of these aequorins; 2) development of a new ratio method of measuring calcium, employing semi-synthetic aequorins; 3) development of a method to produce stabilized preparations of aequorin that are more convenient to transport and use. In addition, sufficient amounts of various kinds of aequorin will be produced for distribution to cell biologists and physiologists for their use in research. The results of this research will be a variety of improved luminescent probes for measurement of free calcium within living cells. These probes, in combination with modern techniques of computer assisted light microscope imaging, will ultimately make it possible to visualize and quantitate the movement of calcium into and out of cells and between intracellular compartments during the response of a cell to a physiological signal.
光蛋白aequorin于1962年首次被P.I.分离出来,作为活细胞中的钙指示物被广泛应用。过去使用的水曲霉素制剂是许多异水曲霉素的未定义混合物。近年来,本实验室制备了三种改进形式的水仙素:1)从异质水仙素中分离得到的均质异水仙素,2)通过分子克隆制备的重组水仙素,以及3)用各种合成类似物取代各种水仙素的官能团获得的半合成水仙素。半合成相思素在测定细胞内钙含量方面具有非常有利的性能,但尚未得到充分利用。该项目的主要目标是提高新型蜂鸟素的可用性。拟开展的研究包括:1)深入研究半合成水仙素的钙激发发光,提高水仙素的有效利用;2)开发了一种新的钙含量比测定方法,采用半合成萘醌;3)开发一种生产更便于运输和使用的稳定制剂的方法。此外,还将生产足够数量的各种黄酮,分发给细胞生物学家和生理学家用于研究。这项研究的结果将是用于测量活细胞内游离钙的各种改进的发光探针。这些探针与现代计算机辅助光学显微镜成像技术相结合,最终将有可能可视化和量化在细胞对生理信号的反应过程中钙进出细胞以及细胞内隔室之间的运动。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Osamu Shimomura其他文献
Glycan expression profile of signet gastric cancer and potential applicability of lectin drug conjugate
印戒胃癌的聚糖表达谱和凝集素药物缀合物的潜在应用
- DOI:
- 发表时间:
2022 - 期刊:
- 影响因子:0
- 作者:
Yoshimsa Akashi;Yu Yang;Osamu Shimomura;Yoshihiro Miyazaki;Tatsuya Oda;et al. - 通讯作者:
et al.
Evaluation of the risk of diarrhea induced by epidermal growth factor receptor tyrosine kinase inhibitors with cultured intestinal stem cells originated from crypts in humans and monkeys.
使用源自人类和猴子隐窝的培养肠干细胞评估表皮生长因子受体酪氨酸激酶抑制剂诱发腹泻的风险。
- DOI:
- 发表时间:
2023 - 期刊:
- 影响因子:3.2
- 作者:
Yoshiki Hashimoto;K. Maeda;Osamu Shimomura;Yoshihiro Miyazaki;S. Hashimoto;Akiko Moriyama;Tatsuya Oda;H. Kusuhara - 通讯作者:
H. Kusuhara
Pancreatic juice out ow in pancreatojejunostomy monitoring with the inter-anastomosis drainage tube; a retrospective observational study
胰肠吻合术中吻合引流管监测胰液流出情况
- DOI:
- 发表时间:
2022 - 期刊:
- 影响因子:0
- 作者:
Osamu Shimomura;Yoshihiro Miyazaki - 通讯作者:
Yoshihiro Miyazaki
Novel therapeutic strategy for pancreatic cancer with lectin drug conjugate (LDC) ~ the Efficacy and pilot Safety test~
凝集素药物结合物(LDC)治疗胰腺癌的新策略〜功效和先导安全性测试〜
- DOI:
- 发表时间:
2018 - 期刊:
- 影响因子:0
- 作者:
Osamu Shimomura;Tatsuya Oda;Hiroaki Tateno;Yusuke Ozawa;Sota Kimura;Shigo Sakashita;Jun Hirabayashi;Masayuki Noguchi;Makoto Asashima;Nobuhiro Ohkohchi - 通讯作者:
Nobuhiro Ohkohchi
Osamu Shimomura的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Osamu Shimomura', 18)}}的其他基金
The detection of early stage pancreatic cancer with sandwich ELISA using tumor specific lectins
使用肿瘤特异性凝集素通过夹心 ELISA 检测早期胰腺癌
- 批准号:
18K16298 - 财政年份:2018
- 资助金额:
$ 28.94万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Improved Aequorin for Monitoring Ca and Superoxide in Cells
改进的水母发光蛋白用于监测细胞中的钙和超氧化物
- 批准号:
9722982 - 财政年份:1997
- 资助金额:
$ 28.94万 - 项目类别:
Continuing Grant
Improved Aequorin for Ca Assay in Functioning Cells
改进的水母发光蛋白用于功能细胞中 Ca 的测定
- 批准号:
9403183 - 财政年份:1994
- 资助金额:
$ 28.94万 - 项目类别:
Continuing Grant
Improved Aequorin for Ca Assay in Functioning Cells
改进的水母发光蛋白用于功能细胞中 Ca 的测定
- 批准号:
8801148 - 财政年份:1988
- 资助金额:
$ 28.94万 - 项目类别:
Continuing Grant
相似海外基金
Aequorin-based Functional Assays for HTS of tyrosine Kinases and Other Cell Surface Receptor Modulators
基于水母发光蛋白的酪氨酸激酶和其他细胞表面受体调节剂 HTS 功能测定
- 批准号:
371306-2008 - 财政年份:2011
- 资助金额:
$ 28.94万 - 项目类别:
Industrial Research Fellowships
Aequorin-based Functional Assays for HTS of tyrosine Kinases and Other Cell Surface Receptor Modulators
基于水母发光蛋白的酪氨酸激酶和其他细胞表面受体调节剂 HTS 功能测定
- 批准号:
371306-2008 - 财政年份:2010
- 资助金额:
$ 28.94万 - 项目类别:
Industrial Research Fellowships
Aequorin-based Functional Assays for HTS of tyrosine Kinases and Other Cell Surface Receptor Modulators
基于水母发光蛋白的酪氨酸激酶和其他细胞表面受体调节剂 HTS 功能测定
- 批准号:
371306-2008 - 财政年份:2009
- 资助金额:
$ 28.94万 - 项目类别:
Industrial Research Fellowships
Beyond GFP and aequorin: Ocean-wide study of fluorescent and luminous proteins
超越 GFP 和水母发光蛋白:荧光和发光蛋白的全海洋研究
- 批准号:
7496415 - 财政年份:2006
- 资助金额:
$ 28.94万 - 项目类别:
Beyond GFP and aequorin: Ocean-wide study of fluorescent and luminous proteins
超越 GFP 和水母发光蛋白:荧光和发光蛋白的全海洋研究
- 批准号:
7133657 - 财政年份:2006
- 资助金额:
$ 28.94万 - 项目类别:
Beyond GFP and aequorin: Ocean-wide study of fluorescent and luminous proteins
超越 GFP 和水母发光蛋白:荧光和发光蛋白的全海洋研究
- 批准号:
7283149 - 财政年份:2006
- 资助金额:
$ 28.94万 - 项目类别:
Beyond GFP and aequorin: Ocean-wide study of fluorescent and luminous proteins
超越 GFP 和水母发光蛋白:荧光和发光蛋白的全海洋研究
- 批准号:
7681463 - 财政年份:2006
- 资助金额:
$ 28.94万 - 项目类别:
Highly sensitive and rapid tandem bioluminescent immunoassay using aequorin labeled Fab fragment and biotinylated firefly luciferase
使用水母发光蛋白标记的 Fab 片段和生物素化的萤火虫荧光素酶进行高灵敏度和快速串联生物发光免疫分析
- 批准号:
17590039 - 财政年份:2005
- 资助金额:
$ 28.94万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Production of new recombinant aequorin and its physiological application
新型重组水母发光蛋白的制备及其生理应用
- 批准号:
13557004 - 财政年份:2001
- 资助金额:
$ 28.94万 - 项目类别:
Grant-in-Aid for Scientific Research (B)














{{item.name}}会员




